Results 211 to 220 of about 2,034,935 (392)
Hematologic Response to Steroid Use in Patients with Primary Immune Thrombocytopenia: A Research Study in a Salvadoran Population [PDF]
Luis Fernando Rivas
openalex +1 more source
Single Cell Analysis Reveals Dynamic Changes of Distinct Cell Populations in Human Nickel Allergy
We investigated cell types mediating the early and late inflammatory responses in human Ni2+‐allergy by scRNA‐Seq. Early responsiveness was mainly mediated by TLR4+TAGLN− endothelial cells indirectly activating TLR4−KRT16+ keratinocytes, and CCR7+DCN+ DCs. Late responsiveness was crucially driven by infiltration of KLF2+ central memory T cells and TLR4+
Marc Schmidt +7 more
wiley +1 more source
Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine
O. H. Tarawneh, Husam S Tarawneh
semanticscholar +1 more source
PO-0165 Predictors Of Chronic Primary Immune Thrombocytopenia [PDF]
L. Sfaihi +6 more
openalex +1 more source
In this single‐center retrospective cohort study, the use of PMX‐HA was significantly associated with a reduced risk of 1‐year mortality in patients with septic shock due to intra‐abdominal infection. In contrast, no significant association was observed between PMX‐HA use and 1‐year mortality risk in patients with septic shock caused by extra‐abdominal
Tomoki Tanaka +9 more
wiley +1 more source
Iron Deficiency in Immune Thrombocytopenia: Are We Doing Enough? [PDF]
Analy Mora +7 more
openalex +1 more source
In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas +18 more
wiley +1 more source
Multicellular Derived S100A8/A9 Maintains Megakaryocytes in an Immature State in Immune Thrombocytopenia [PDF]
Jiaqian Qi +5 more
openalex +1 more source
A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination
E King, Elizabeth Towner
openalex +1 more source
Summary The efficacy of ciclosporin (CsA) to treat transfusion‐independent non‐severe aplastic anaemia (TI‐NSAA) has not yet been systematically evaluated. We conducted a prospective trial in patients with TI‐NSAA treated with CsA monotherapy. CsA (3.5 mg/kg/day) was administered to patients with TI‐NSAA aged ≥16.
Ken Ishiyama +14 more
wiley +1 more source

